Clinical Research Directory
Browse clinical research sites, groups, and studies.
Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertension
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
Summary
The goal of this study is to test the hypothesis that hydroxyurea is effective for the specific treatment of secondary pulmonary hypertension found on screening in children and young adults with sickle cell disease.
Official title: A Pilot Study of Hydroxyurea for the Treatment of Pulmonary Hypertension in Children and Young Adults With Sickle Cell Disease
Key Details
Gender
All
Age Range
10 Years - 25 Years
Study Type
INTERVENTIONAL
Enrollment
6
Start Date
2006-07
Completion Date
2008-06
Last Updated
2026-09-24
Healthy Volunteers
No
Interventions
Hydroxyurea
Drug to be initiated at standard starting dose with dose escalation until maximum tolerated dose reached.
Locations (1)
Ann & Robert H Lurie Children's Hospital of Chicago
Chicago, Illinois, United States